Diagnos Laboratorium Utama PT Tbk
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want t… Read more
Diagnos Laboratorium Utama PT Tbk (DGNS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.008x
Based on the latest financial reports, Diagnos Laboratorium Utama PT Tbk (DGNS) has a cash flow conversion efficiency ratio of 0.008x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp1.52 Billion) by net assets (Rp194.00 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Diagnos Laboratorium Utama PT Tbk - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Diagnos Laboratorium Utama PT Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Diagnos Laboratorium Utama PT Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diagnos Laboratorium Utama PT Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Metal Bank Ltd
AU:MBK
|
-0.023x |
|
Ouster, Inc. Warrants
NYSE:OUSTZ
|
-0.074x |
|
Wilson Bayly Holmes Ovcon Ltd
JSE:WBO
|
0.150x |
|
GREENROC MINING LS-001
F:3WF
|
N/A |
|
Xcel Brands Inc
NASDAQ:XELB
|
-0.057x |
|
Galantas Gold Corporation
OTCQX:GALKF
|
0.127x |
|
Privasia Technology Bhd
KLSE:0123
|
0.057x |
|
Cheetah Net Supply Chain Service Inc. Class A Common Stock
NASDAQ:CTNT
|
-0.059x |
Annual Cash Flow Conversion Efficiency for Diagnos Laboratorium Utama PT Tbk (2017–2024)
The table below shows the annual cash flow conversion efficiency of Diagnos Laboratorium Utama PT Tbk from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp196.13 Billion | Rp27.30 Billion | 0.139x | +106.49% |
| 2023-12-31 | Rp195.59 Billion | Rp13.18 Billion | 0.067x | +335.77% |
| 2022-12-31 | Rp210.43 Billion | Rp-6.02 Billion | -0.029x | -109.80% |
| 2021-12-31 | Rp201.80 Billion | Rp58.87 Billion | 0.292x | +10.19% |
| 2020-12-31 | Rp99.07 Billion | Rp26.23 Billion | 0.265x | +9.86% |
| 2019-12-31 | Rp46.46 Billion | Rp11.20 Billion | 0.241x | -62.25% |
| 2018-12-31 | Rp13.27 Billion | Rp8.47 Billion | 0.638x | +388.54% |
| 2017-12-31 | Rp3.22 Billion | Rp-712.00 Million | -0.221x | -- |